Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function

Neurology

Volumn 74, Issue 13, 2010, Pages 1022-1029

  Wersching, H ^a,b   Duning, T ^a   Lohmann, H ^a   Mohammadi, S ^a   Stehling, C ^c   Fobker, M ^d   Conty, M ^a   Minnerup, J ^a   Ringelstein, E B ^a   Berger, K ^b   Deppe, M ^a   Knecht, S ^a  

^a Department of Neurology ^*  (United States)

^b Institute of Epidemiology and Social Medicine   (United States)

^c Institute of Clinical Radiology   (United States)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANISOTROPY; ARTICLE; AUTOMATION; BRAIN ATROPHY; BRAIN CIRCULATION; BRAIN REGION; BRAIN SIZE; COGNITION; CORPUS CALLOSUM; DEMENTIA; DIFFUSION TENSOR IMAGING; DISEASE MARKER; FEMALE; FRONTAL LOBE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOMETRY; QUANTITATIVE ANALYSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE; VERBAL MEMORY; WHITE MATTER;

EID: 77950256167     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181d7b45b     Document Type: Article

References (39)

1. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-1565.
2. Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001;32: 2575-2579.
3. Schmidt R, Schmidt H, Curb JD, et al. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002;52:168-174.
4. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-2041.
5. Hoshi T, Kitagawa K, Yamagami H, et al. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 2005;36:768-772.
6. van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005;112:900-905.
7. Fornage M, Chiang YA, O'Meara ES, et al. Biomarkers of inflammation and MRI-defined small vessel disease of the brain: The Cardiovascular Health Study. Stroke 2008;39: 1952-1959.
8. Gunstad J, Bausserman L, Paul RH, et al. C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci 2006;13:540-546.
9. Schmidt R, Schmidt H, Pichler M, et al. C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study. Stroke 2006;37:2910-2916.
10. Deppe M, Duning T, Mohammadi S, et al. Diffusion-tensor imaging at 3 T: detection of white matter alterations in neurological patients on the basis of normal values. Invest Radiol 2007;42:338-345.
11. Assaf Y, Pasternak O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review. J Mol Neurosci 2008;34:51-61.
12. Schiavone F, Charlton RA, Barrick TR, Morris RG, Markus HS. Imaging age-related cognitive decline: a comparison of diffusion tensor and magnetization transfer MRI. J Magn Reson Imaging 2009;29:23-30.
13. Knecht S, Wersching H, Lohmann H, et al. High-normal blood pressure is associated with poor cognitive performance. Hypertension 2008;51:663-668.
14. Lezak MD. Neuropsychological Assessment, 4th ed. New York: Oxford University Press; 2004.
15. Scheltens P, Erkinjunti T, Leys D, et al. White matter changes on CT and MRI: an overview of visual rating scales: European Task Force on Age-Related White Matter Changes. Eur Neurol 1998;39:80-89.
16. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479-489.
17. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
18. Hoth KF, Haley AP, Gunstad J, et al. Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. J Am Geriatr Soc 2008;56:1898-1903.
19. Wright CB, Sacco RL, Rundek TR, et al. Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. J Stroke Cerebrovasc Dis 2006;15:34-38.
20. Carlson MC, Xue QL, Zhou J, Fried LP. Executive decline and dysfunction precedes declines in memory: the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci 2009;64:110-117.
21. Jefferson AL, Paul RH, Ozonoff A, Cohen RA. Evaluating elements of executive functioning as predictors of instrumental activities of daily living (IADLs). Arch Clin Neuro-psychol 2006;21:311-320.
22. Gouw AA, Seewann A, Vrenken H, et al. Heterogeneity of white matter hyperintensities in Alzheimer's disease: postmortem quantitative MRI and neuropathology. Brain 2008;131:3286-3298.
23. Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 1999;42:515-525.
24. Nitkunan A, Barrick TR, Charlton RA, Clark CA, Markus HS. Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke 2008;39:1999-2005.
25. Zacho J, Tybjaerg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897-1908.
26. Reitz C, Berger K, de Maat MP, et al. CRP gene haplo-types, serum CRP, and cerebral small-vessel disease: the Rotterdam Scan Study and the MEMO Study. Stroke 2007;38:2356-2359.
27. Das I. Raised C-reactive protein levels in serum from smokers. Clin Chim Acta 1985;153:9-13.
28. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-2135.
29. Hassan A, Hunt BJ, O'Sullivan M, et al. Markers of endo-thelial dysfunction in lacunar infarction and ischaemic leu-koaraiosis. Brain 2003;126:424-432.
30. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-2168.
31. Meier-Ruge W, Ulrich J, Bruhlmann M, Meier E. Age-related white matter atrophy in the human brain. Ann NY Acad Sci 1992;673:260-269.
32. Kritchevsky SB, Cesari M, Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 2005;66:265-275.
33. Dik MG, Jonker C, Hack CE, et al. Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005;64:1371-1377.
34. Weuve J, Ridker PM, Cook NR, Buring JE, Grodstein F. High-sensitivity C-reactive protein and cognitive function in older women. Epidemiology 2006;17:183-189.
35. Ockene IS, Matthews CE, Rifai N, et al. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001; 47:444-450.
36. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hen-nekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
37. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
38. Lakka TA, Lakka HM, Rankinen T, et al. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. Eur Heart J 2005; 26:2018-2025.
39. Witte AV, Fobker M, Gellner R, Knecht S, Floel A. Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci USA 2009;106:1255-1260